Your body eliminates cholesterol primarily through the liver, which converts it into bile acids and pumps it into the digestive tract, where it eventually leaves in stool. This liver-centered process accounts for the largest share of cholesterol disposal, but it is not the only route. A second major pathway runs directly through the intestinal wall, gut bacteria chemically modify some cholesterol into a form that cannot be reabsorbed, and even the skin contributes a small amount. How efficiently all of these systems work depends on your genetics, diet, gut microbiome, and the time of day.
The Liver Converts Cholesterol Into Bile Acids
The single biggest way your body gets rid of cholesterol is by turning it into bile acids. This conversion happens in liver cells and is kicked off by an enzyme called CYP7A1, which performs the first and rate-limiting step in what researchers call the “classic” bile acid synthesis pathway.1PubMed Central. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis Think of CYP7A1 as the bottleneck: however much cholesterol your liver has on hand, the speed of this one enzyme largely determines how fast that cholesterol becomes bile acid. People who are born with mutations in the gene for CYP7A1 end up with high cholesterol precisely because this exit route is impaired.2JCI Insight. Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
There is also an “acidic” or alternative pathway that begins with a different enzyme, CYP27A1, located in the mitochondria of many cell types, not just liver cells.3PubMed Central. The acidic pathway of bile acid synthesis: Not just an alternative pathway This backup route normally contributes a smaller share of total bile acid production, but it becomes more important when the classic pathway is compromised.4Journal of Lipid Research. Alternate pathways of bile acid synthesis in the cholesterol 7α-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding The bile acids produced by both pathways are secreted into the small intestine, where they help digest dietary fat. After doing their job, most bile acids are reabsorbed in the lower small intestine and shuttled back to the liver to be recycled, a loop called the enterohepatic circulation.5PubMed Central. Role of the intestinal bile acid transporters in bile acid and drug disposition Only a fraction escapes reabsorption and leaves the body in stool, and that fraction represents the net cholesterol your body has permanently discarded.
How Cholesterol Reaches the Liver in the First Place
Cholesterol circulating in your blood does not spontaneously drift into liver cells. It has to be delivered, and the main delivery service is a process called reverse cholesterol transport. The basic idea: HDL particles (often called “good cholesterol”) collect excess cholesterol from tissues and ferry it to the liver for disposal.
The collection step depends heavily on two transporter proteins on the surface of cells, especially the foam cells inside artery walls that are central to plaque formation. These transporters, ABCA1 and ABCG1, actively pump cholesterol out of cells and onto waiting HDL particles.6PubMed Central. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses Mouse studies have shown that knocking out either transporter reduces cholesterol removal from tissues, and knocking out both at once causes an even larger drop, confirming they work together in an additive way.7PubMed Central. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo Some cholesterol also leaves cells passively, without any transporter assistance, but this passive efflux is less efficient.
Once cholesterol is loaded onto HDL, the particles travel to the liver and dock with a receptor called SR-BI. This receptor was the first well-characterized HDL receptor identified, and it works in an unusual way: instead of swallowing the entire HDL particle, it selectively extracts the cholesterol cargo and lets the stripped-down particle float back into circulation to pick up more.8PubMed. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor In mice, cutting hepatic SR-BI expression by half reduced selective cholesterol uptake by the liver by roughly 47%, underscoring how central this receptor is to the whole process.9PubMed. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol
Pumping Cholesterol Directly Into Bile
Not all of the cholesterol that arrives at the liver gets converted into bile acids. Some of it is pumped out as free cholesterol directly into bile, where it joins bile acids and another lipid called phosphatidylcholine to form the liquid that drains into your gallbladder and eventually your small intestine. The transporters responsible are a pair called ABCG5 and ABCG8, which sit on the surface of liver cells and work as a team: one without the other does not function properly.10PubMed. Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion
When researchers disrupted both genes in mice, biliary cholesterol concentrations plummeted from about 5.5 to just 0.4 micromoles per milliliter, showing that ABCG5 and ABCG8 are responsible for the vast majority of cholesterol secretion into bile.11PubMed Central. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion Conversely, overexpressing these two transporters boosted biliary cholesterol output and reduced how much dietary cholesterol was absorbed from food.12PubMed Central. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol So this pair of proteins acts as a gatekeeper in two directions at once: pushing cholesterol out of the body through bile while also limiting how much sneaks in from the diet.
A Second Exit Through the Intestinal Wall
For decades, scientists assumed the liver-to-bile route was essentially the only way cholesterol left the body. Then research revealed a second major pathway: transintestinal cholesterol excretion, or TICE. In this process, intestinal cells pull cholesterol from the blood on their inner surface and shuttle it across to the outer surface facing the gut lumen, effectively dumping it into the digestive tract without any involvement from bile at all.13PubMed Central. The TICE Pathway: Mechanisms and Lipid-Lowering Therapies
TICE is not a minor curiosity. Researchers now consider it a second major disposal pathway alongside biliary secretion.14PubMed. Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1 The pathway is actively regulated by some of the same proteins that influence LDL metabolism, including PCSK9 and the machinery targeted by statins. This makes TICE a potential drug target in its own right, and ongoing research is exploring whether boosting it could lower cholesterol in people who do not respond well to conventional therapies.
What Your Gut Bacteria Do to Cholesterol
Before cholesterol that has been dumped into the gut can leave your body, it faces one more possible fate: conversion by bacteria. Certain gut microbes transform cholesterol into coprostanol, a structurally similar molecule that the intestine cannot reabsorb. Once converted, coprostanol passes straight through and is excreted in stool.15PubMed Central. Cholesterol-to-Coprostanol Conversion by the Gut Microbiota: What We Know, Suspect, and Ignore
Research has begun to identify the specific enzymes these bacteria use. One key study found that a bacterial enzyme oxidizes cholesterol to an intermediate compound and then reduces it to coprostanol, completing both the first and last steps of the conversion.16Cell Host & Microbe. Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level The same study linked the presence of these cholesterol-metabolizing bacteria to lower cholesterol levels in people who carried them. Not everyone has a gut microbiome that performs this conversion efficiently, which may partly explain why some individuals have stubbornly high cholesterol despite otherwise similar diets and lifestyles. The idea of deliberately seeding the gut with coprostanol-producing bacteria is still early-stage, but it represents a genuinely novel angle on cholesterol management.
How Diet Influences Cholesterol Disposal
Two dietary strategies directly tap into the elimination pathways described above: soluble fiber and plant sterols. They work through different mechanisms, but both end up increasing the amount of cholesterol that leaves the body through stool.
Soluble fiber, found in oats, barley, beans, and certain fruits, binds to bile acids in the small intestine and prevents them from being reabsorbed during the enterohepatic circulation. When fewer bile acids return to the liver, the liver compensates by pulling more cholesterol out of the bloodstream to synthesize new ones. At the same time, the liver increases its surface receptors for LDL, drawing more LDL particles out of circulation.17ACS Omega. Soluble Dietary Fibers as Antihyperlipidemic Agents: A Comprehensive Review to Maximize Their Health Benefits The net effect is lower blood cholesterol, achieved not by blocking production but by accelerating an exit pathway that already exists.
Plant sterols (also called phytosterols, found naturally in nuts, seeds, and vegetable oils and added to some margarines) work differently. Their molecular structure is similar enough to cholesterol that they compete for the same absorption machinery in the gut. Research has shown that plant sterols displace cholesterol from the tiny fat-and-bile-acid clusters that carry it across the intestinal lining.18Journal of Lipid Research. Inhibition of cholesterol absorption in rats by plant sterols In one human study, adding beta-sitosterol to meals reduced cholesterol absorption by about 42%.19PubMed. Optimizing the effect of plant sterols on cholesterol absorption in man The unabsorbed cholesterol passes through and is excreted. This is less about boosting an active elimination pathway and more about preventing cholesterol from entering the body in the first place, but the practical outcome is the same: less cholesterol in the blood.
Medications That Target Elimination Pathways
Many cholesterol-lowering drugs work by interfering with cholesterol production, but several specifically act on removal pathways. Understanding which pathway each one targets helps explain why certain drugs are combined.
Ezetimibe blocks cholesterol absorption in the small intestine by targeting a protein called NPC1L1, which sits on the surface of intestinal cells and acts as the main gateway for cholesterol to enter. Ezetimibe binds to NPC1L1 and prevents it from being pulled into the cell along with its cholesterol cargo, essentially locking the gate shut.20PubMed. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1 Structural studies have shown that ezetimibe does not simply compete with cholesterol for a binding site; it blocks a transport tunnel within the protein, physically preventing cholesterol from passing through.21PubMed Central. Cryo-EM structures of NPC1L1 reveal mechanisms of cholesterol transport and ezetimibe inhibition Because this mechanism is entirely different from how statins work (statins reduce production; ezetimibe reduces absorption), the two are often prescribed together.
Bile acid sequestrants, an older class of drugs, work on the same principle as soluble fiber but more aggressively. They bind bile acids in the gut and force the liver to pull more cholesterol from the blood to make replacement bile acids. Newer research has focused on a different target: the ASBT transporter in the lower small intestine, which is responsible for recapturing bile acids during the enterohepatic circulation.22PubMed. Metabolic consequences of ileal interruption of the enterohepatic circulation of bile acids By blocking ASBT, experimental drugs aim to let more bile acids escape into stool, forcing the liver to convert more cholesterol to replace them.
PCSK9 inhibitors take yet another approach. PCSK9 is a protein that marks LDL receptors on liver cells for destruction. Fewer receptors means less LDL is cleared from the blood. By blocking PCSK9, these drugs preserve LDL receptors and allow the liver to pull more LDL cholesterol out of circulation for disposal.23PubMed Central. PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells This does not directly increase the body’s cholesterol excretion rate, but it channels more cholesterol into the liver, where it becomes available for conversion to bile acids or secretion into bile.
When Cholesterol Disposal Breaks Down
The clearest illustration of how important these pathways are comes from people born with mutations that disable them. Sitosterolemia is a rare genetic condition caused by mutations in either the ABCG5 or the ABCG8 gene, the same transporter pair that pumps cholesterol (and plant sterols) out of liver cells and intestinal cells.24PubMed Central. Sitosterolemia: Twenty Years of Discovery of the Function of ABCG5ABCG8 Without functioning transporters, plant sterols and cholesterol that would normally be excreted build up in the blood and tissues instead.
The consequences go well beyond high cholesterol. People with sitosterolemia can develop premature atherosclerosis, abnormal platelet function, and low platelet counts, along with potential liver problems.25Journal of Lipid Research. ABCG5 and ABCG8: Keys to managing whole body cholesterol and plant sterol homeostasis The condition is caused by a mutation in one gene or the other, never both simultaneously, because the two proteins function as an obligate pair.26PubMed Central. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease Studying sitosterolemia was actually what led scientists to discover ABCG5 and ABCG8 in the first place, which then reshaped the broader understanding of how the body manages sterol balance in everyone.
Similarly, mutations in the CYP7A1 gene, the enzyme that starts bile acid synthesis, cause a form of high cholesterol because the main conversion pathway from cholesterol to bile acids is crippled. And defects in the LDL receptor itself cause familial hypercholesterolemia, the most common serious genetic cholesterol disorder, in which the liver simply cannot pull enough LDL out of the blood regardless of how well every other pathway works.
Cholesterol Elimination Follows a Clock
Your body does not process cholesterol at a constant rate throughout the day. Cholesterol synthesis peaks during the night and drops during the daytime, a rhythm driven by the same internal clock genes that regulate sleep and metabolism.27PubMed Central. Diurnal Variation of Markers for Cholesterol Synthesis, Cholesterol Absorption, and Bile Acid Synthesis: A Systematic Review and the Bispebjerg Study of Diurnal Variations The rate-limiting enzyme in cholesterol production, HMG-CoA reductase, follows this circadian pattern, which is the original reason doctors used to recommend taking statins at bedtime: the drugs would be at peak concentration in the blood exactly when the enzyme they inhibit was most active. Newer statins with longer half-lives can be taken at any time of day, but the underlying biology has not changed.
Bile acid synthesis and cholesterol absorption also show time-of-day variation, though these rhythms are less dramatic and are influenced by when you eat. The practical upshot is that meal timing and sleep patterns can modestly affect how efficiently your body clears cholesterol. Shift workers and people with chronically disrupted sleep schedules tend to have worse lipid profiles, and circadian disruption is one plausible contributing factor, though disentangling it from the many other metabolic effects of poor sleep is difficult.
Minor Routes and Unconventional Exits
The liver-bile-gut axis and the TICE pathway handle the overwhelming majority of cholesterol disposal, but small amounts leave the body through other channels. The skin, for example, secretes cholesterol through sebum, the oily substance produced by sebaceous glands. Researchers have discussed a potential link between sebum secretion and overall lipid balance, suggesting the skin may play a minor role in cholesterol homeostasis.28PubMed Central. The skin function: a factor of anti-metabolic syndrome Cholesterol is also used as the raw material for making steroid hormones and vitamin D, which effectively consumes some of the body’s cholesterol supply, although these pathways are more about cholesterol utilization than elimination. None of these routes move enough cholesterol to meaningfully affect blood levels on their own, but they are part of the broader picture of how your body keeps cholesterol in balance.
One ancient piece of this system that sometimes surprises people is how deeply conserved it is across species. Bile acids evolved very early in vertebrate history, and the receptor that senses them in your liver still responds to the primitive bile alcohols found in fish and amphibians.29PubMed. Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor The basic blueprint for disposing of cholesterol through bile has been in place for hundreds of millions of years, tweaked and refined but never fundamentally redesigned. The elegance and the vulnerability of the system are two sides of the same coin: it works remarkably well in most people most of the time, but because so many steps depend on specific proteins and transporters, a single genetic hiccup at any point in the chain can throw the whole thing off.